Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeted therapy in esophageal cancer.

Expert review of gastroenterology & hepatology - 1 Jan 2016

Zhang Lei, Ma Jiaojiao, Han Yu, Liu Jinqiang, Zhou Wei, Hong Liu, Fan Daiming

Abstract excerpt

An increasing number of patients are diagnosed with esophageal cancer at an advanced stages, and only a small group of them can benefit from the traditional chemotherapy and radiotherapy. So far, multiple monoclonal antibodies and tyrosine kinase inhibitors have been developed, alone or in combination with traditional therapy, to improve the prognosis of patients with advanced esophageal cancer. This review...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Proto-Oncogene Proteins c-met
Share to Receptor, ErbB-2
Share to Molecular Diagnostic Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Targeted Therapy

Share to Precision Medicine

Share to Angiogenesis Inhibitors

Share to Esophageal Neoplasms

Share to Receptors, Vascular Endothelial Growth Factor

Source

Identifiers

PMID: 26895097
DOI: 10.1586/17474124.2016.1140036

Genes

EGFR
MET

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeted therapy in esophageal cancer.PMID 26895097Read ↗

Targeted Therapies in Neoadjuvant Treatment for Gastroesophageal CancerSemantic proximity Read ↗

Personalized targeted therapy for esophageal squamous cell carcinoma.Semantic proximity Read ↗

New Strategies in Esophageal Carcinoma: Translational Insights from Signaling Pathways and Immune CheckpointsSemantic proximity Read ↗

Old Tyrosine Kinase Inhibitors and Newcomers in Gastrointestinal Cancer Treatment.Semantic proximity Read ↗

Esophageal cancer: Risk factors, genetic association, and treatment.Semantic proximity Read ↗

Pharmacokinetics and pharmacogenomics in esophageal cancer chemoradiotherapy.Semantic proximity Read ↗

Molecular mechanisms associated with chemoresistance in esophageal cancer.Semantic proximity Read ↗

Management of Patients With Adenocarcinoma or Squamous Cancer of the Esophagus.Semantic proximity Read ↗

Clinical impact of tumour biology in the management of gastroesophageal cancer.Semantic proximity Read ↗

Epidermal growth factor receptor dual-target inhibitors as a novel therapy for cancer: A review.Semantic proximity Read ↗

PD-1 Inhibitor Plus Chemotherapy Versus Chemotherapy for First-Line Treatment in Advanced Esophageal Cancer: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Current and future therapies for targeting HER2 mutations in gastrointestinal cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.